Apr 17, 2025
1:3
For every 3 shares held, investors received 1.
The split itself did not change the total investment value.
Tvardi Therapeutics, Inc. (GETTEX:69C) operates in the Biotechnology industry.
Tvardi Therapeutics, Inc. company overviewTvardi Therapeutics, Inc.'s most recent stock split was on April 17, 2025. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
Tvardi Therapeutics, Inc. (GETTEX:69C) has split its stock 2 times: a 1-for-12 reverse split on December 31, 2024 and a 1-for-3 reverse split on April 17, 2025.
Tvardi Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between December 31, 2024 and April 17, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Tvardi Therapeutics, Inc.'s 1-for-3 reverse split on April 17, 2025, every 3 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Tvardi Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 17, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:69C split will appear on this page.